Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

2008860 citationsJournal Article

Authors

Good health and well-being

Published in: American Journal of Ophthalmology

Volume 145, Issue 2, pp. 239-248.e5

Field-Weighted Citation Impact: 76.13